BACKGROUND: The CD23 molecule has an effect on the regulation of IgE synthesis, either by stimulation or inhibition. It is not yet known whether the expression of CD23 on B lymphocytes is related to the level of allergen-specific IgE antibodies in patients with atopic dermatitis. AIM: The aim of this pilot study was to evaluate the association between the expression of CD23 molecule on B cells and on their subsets (memory, naive, switched, non-switched, and total B lymphocytes) and the level of specific IgE to molecular components of mites in atopic dermatitis patients (with and without dupilumab therapy). METHODS: Forty-five patients suffering from atopic dermatitis were included: 32 patients without dupilumab treatment (10 men, 22 women, average age 35 years), 13 patients with dupilumab treatment (7 men, 6 women, average age 43.4 years) and 30 subjects as a control group (10 men, 20 women, average age 44.7 years). The serum level of the specific IgE was measured using the components resolved diagnostic microarray-based specific IgE detection assay ALEX2 Allergy Xplorer. In all included patients, the expression of CD23 molecule on B lymphocytes was evaluated with flow cytometry using monoclonal antibodies. For the statistical analysis of the association between expression of CD23 molecule on B lymphocytes and the level of specific IgE to molecular components of mites, we used non-parametric Kruskal-Wallis one-factor analysis of variance with post-hoc by Dunn's test with Bonferroni modification and the Spearman's rank correlation coefficient; for coefficients higher than 0.41, we report R2 (%, percent of Variation Explained). RESULTS: The association between the expression of CD23 molecule on B cells and the level of specific IgE to molecular components of mites was confirmed only in patients with dupilumab therapy. In these patients, the highest association was confirmed between the level of specific IgE to Der p 20 and expression of CD23 on switched B lymphocytes (in 48.9%). In patients without dupilumab, the association between the level of specific IgE to molecular components of mites and the expression of CD23 on B cells and on their subsets is low. CONCLUSION: Further research is needed to fully understand the underlying mechanism of this phenomenon and its implications for the treatment of atopic dermatitis.

Department of Clinical Immunology and Allergy Faculty Hospital and Medical Faculty of Charles University Hradec Králové Czech Republic

Department of Dermatology and Venereology Faculty Hospital and Medical Faculty of Charles University Hradec Králové Czech Republic

Department of Medical Biophysics Medical Faculty of Charles University Hradec Králové Czech Republic

Zobrazit více v PubMed

Wollenberg A, Thomsen SF, Lacour JP, Jaumont X, Lazarewicz S. Targeting immunoglobulin E in atopic dermatitis: a review of the existing evidence. World Allergy Organ J. 2021;14(3):100519. 10.1016/j.waojou.2021.100519 PubMed DOI PMC

Schwarzmeier JD, Hubmann R, Düchler M, Jäger U, Shehata M. Regulation of CD23 expression by Notch2 in B‐cell chronic lymphocytic leukemia. Leuk Lymphoma. 2005;46(2):157‐165. 10.1080/10428190400010742 PubMed DOI

Engeroff P, Vogel M. The role of CD23 in the regulation of allergic responses. Allergy. 2021;76(7):1981‐1989. 10.1111/all.14724 PubMed DOI PMC

Engeroff P, Caviezel F, Mueller D, Thoms F, Bachmann MF, Vogel M. CD23 provides a noninflammatory pathway for IgE‐allergen complexes. J Allergy Clin Immunol. 2020;145(1):301‐311. Epub 2019 Aug 19. PMID: 31437490. 10.1016/j.jaci.2019.07.045 PubMed DOI

Selb R, Eckl‐Dorna J, Neunkirchner A, et al. CD23 surface density on B cells is associated with IgE levels and determines IgE‐facilitated allergen uptake, as well as activation of allergen‐specific T cells. J Allergy Clin Immunol. 2017;139(1):290‐299. 10.1016/j.jaci.2016.03.042 PubMed DOI PMC

Seegräber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expet Rev Clin Pharmacol. 2018;11(5):467‐474. 10.1080/17512433.2018.1449642 PubMed DOI

Čelakovská J, Čermáková E, Boudková P, Andrýs C, Krejsek J. Evaluation of leukocytes, B and T lymphocytes, and expression of CD200 and CD23 on B lymphocytes in patients with atopic dermatitis on dupilumab therapy—pilot study. Dermatol Ther (Heidelb). 2023;13(5):1171‐1192. 10.1007/s13555-023-00918-y PubMed DOI PMC